The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,310.00
Bid: 4,285.00
Ask: 4,310.00
Change: 0.00 (0.00%)
Spread: 25.00 (0.583%)
Open: 4,310.00
High: 4,310.00
Low: 4,310.00
Prev. Close: 4,310.00
CWK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

5 Mar 2018 07:00

RNS Number : 6120G
Cranswick PLC
05 March 2018
 

5 March 2018

Cranswick plc("Cranswick" or "the Company" or "the Group")

Directorate changes

Cranswick plc announces the appointment, with effect from 1 April 2018, of Pam Powell and Tim Smith as independent non-executive directors of the Company.

Pam Powell

Pam has a long and successful international career in strategy, marketing and innovation in fast moving consumer goods, including latterly, food and beverages. Pam spent nine years at SABMiller plc, holding the position of Group Director of Strategy and Innovation, and prior to this, worked at Coty Europe in France, Unilever plc in London, and Lever Brothers in New York.

Pam is currently a non-executive director of Premier Foods plc and A.G. Barr plc. No other information on Pam is required to be disclosed pursuant to Listing Rule 9.6.13R.

Tim Smith

Tim has extensive experience of the UK food sector having worked in food manufacturing, government regulation and supermarket retail during his career.

Most recently, Tim worked at Tesco plc between 2012 and 2017 as its Group Quality Director where he was responsible for product development, responsible sourcing, quality and technical matters. Prior to joining Tesco, Tim was the Chief Executive of the Food Standards Agency between 2008 and 2012 during which time he led a strategic review of the agency and also developed strong relationships with regulatory organisations and government in the UK and the rest of the world. Before joining the Food Standards Agency, Tim led a number of food manufacturing businesses including Express Dairies plc and Arla Foods plc where Tim became Chief Executive in 2005 with responsibility for delivery of the group's strategic plan including a £180million investment programme. Tim also sits on the board of a number of food industry and charitable bodies.

No other information on Tim is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

Martin Davey, Chairman of Cranswick plc, commented:

"I am delighted that Pam and Tim will be joining our board. They bring significant additional expertise and sector experience which the Group will benefit from as it continues to move forward and develop."

 

 

For further information, please contact:

Enquiries:

Cranswick plc

01482 372 000

Mark Bottomley, Finance Director

 

 

 

Powerscourt

020 7250 1446

Nick Dibden / Lisa Kavanagh

cranswick@powerscourt-group.com

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, premium fresh and cooked poultry, charcuterie and pastry products. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2017 showed revenue from continuing operations of £1,245m and profit before tax on the same basis of £77.5m.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUSUBRWAAORAR
Date   Source Headline
6th Feb 202310:00 amRNSTotal Voting Rights
2nd Feb 20237:00 amRNSThird quarter trading statement
23rd Jan 20239:30 amRNSAdditional Listing
18th Jan 202312:25 pmRNSTotal Voting Rights
6th Jan 202310:57 amRNSDirector/PDMR Shareholding
3rd Jan 202311:43 amRNSDirector/PDMR Shareholding
22nd Dec 202211:20 amRNSCranswick Scrip Dividend Scheme
2nd Dec 20225:47 pmRNSHolding(s) in Company
2nd Dec 20225:07 pmRNSHolding(s) in Company
29th Nov 20227:30 amRNSDirectorship
25th Nov 20221:48 pmRNSHolding(s) in Company
23rd Nov 20223:09 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSInterim Results
16th Nov 20223:14 pmRNSHolding(s) in Company
3rd Nov 20222:55 pmRNSHolding(s) in Company
14th Oct 202211:33 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Oct 202211:31 amRNSBLOCK LISTING SIX MONTHLY RETURN
3rd Oct 20227:00 amRNSTotal Voting Rights
15th Sep 202211:13 amRNSDirector/PDMR Shareholding
15th Sep 202211:12 amRNSDirector/PDMR Shareholding
13th Sep 20223:46 pmRNSDirector/PDMR Shareholding
13th Sep 20223:46 pmRNSDirector/PDMR Shareholding
13th Sep 20223:43 pmRNSDirector/PDMR Shareholding
13th Sep 20223:42 pmRNSDirector/PDMR Shareholding
9th Sep 202211:14 amRNSDirector/PDMR Shareholding
1st Sep 202210:00 amRNSTotal Voting Rights
31st Aug 20221:40 pmRNSTotal Voting Rights
31st Aug 20221:38 pmRNSAdditional Listing
15th Aug 20228:51 amRNSDirectorship
10th Aug 20222:49 pmRNSDirector/PDMR Shareholding
2nd Aug 20224:16 pmRNSHolding(s) in Company
1st Aug 20224:41 pmRNSPoll Result for 2022 Annual General Meeting
1st Aug 20224:15 pmRNSTotal Voting Rights
1st Aug 20227:00 amRNSFirst quarter trading statement
29th Jul 20221:02 pmRNSDividend Declaration
5th Jul 20223:03 pmRNSDirector/PDMR Shareholding
5th Jul 20223:02 pmRNSDirector/PDMR Shareholding
5th Jul 20223:00 pmRNSDirector/PDMR Shareholding
5th Jul 20222:59 pmRNSDirector/PDMR Shareholding
5th Jul 20222:58 pmRNSDirector/PDMR Shareholding
4th Jul 20221:25 pmRNSTotal Voting Rights
4th Jul 202211:12 amRNSDirector/PDMR Shareholding
4th Jul 202211:10 amRNSDirector/PDMR Shareholding
4th Jul 202211:05 amRNSDirector/PDMR Shareholding
4th Jul 202211:01 amRNSDirector/PDMR Shareholding
28th Jun 20229:44 amRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSDirector Appointments
22nd Jun 20221:36 pmRNSDirector Declaration
21st Jun 202212:58 pmRNSDirector Declaration
6th Jun 202210:11 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.